Muscular Dystrophy Trial, Recruiting (NCT06316778)

Muscular Dystrophy Trial, Recruiting NCT06316778 Sponsor: Université de Sherbrooke Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06316778 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been officially diagnosed with myotonic dystrophy type 1 (DM1) with an adult form of the condition
You experience leaking urine due to stress (such as when coughing or sneezing), sudden urges to urinate, or a combination of both
You are able to give your own free and informed agreement to take part in the study

Who may not be able to join:

You are currently pregnant, gave birth vaginally within the last year, or plan to become pregnant in the next six months
Your bladder does not empty fully, leaving 150 ml or more of urine behind after you urinate (confirm with trial site)
You have other health conditions that could affect your bladder leakage symptoms or how well treatments work (confirm with trial site)
You have bowel leakage happening at least once a week, or a significant pelvic organ prolapse (confirm with trial site)
You have already had physiotherapy for your pelvic floor muscles, or have had surgery in the pelvic area
You have an implanted device such as a defibrillator, pacemaker, or bladder stimulator

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06316778

Sponsor: Université de Sherbrooke

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

More information: https://clinicaltrials.gov/study/NCT06316778

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been officially diagnosed with myotonic dystrophy type 1 (DM1) with an adult form of the condition
You experience leaking urine due to stress (such as when coughing or sneezing), sudden urges to urinate, or a combination of both
You are able to give your own free and informed agreement to take part in the study

Who may not be able to join:

You are currently pregnant, gave birth vaginally within the last year, or plan to become pregnant in the next six months
Your bladder does not empty fully, leaving 150 ml or more of urine behind after you urinate (confirm with trial site)
You have other health conditions that could affect your bladder leakage symptoms or how well treatments work (confirm with trial site)
You have bowel leakage happening at least once a week, or a significant pelvic organ prolapse (confirm with trial site)
You have already had physiotherapy for your pelvic floor muscles, or have had surgery in the pelvic area
You have an implanted device such as a defibrillator, pacemaker, or bladder stimulator

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Université de Sherbrooke

Registry

ClinicalTrials.gov

Start date

11 March 2024

Est. completion

30 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Percentage of attended treatment sessions; Percentage of home exercises performed; Retention rate; Recruitment rate; Intervention Acceptability Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov